Clinical trials in Slezska Ostrava

Leading investigations into cardiovascular disease prevention and treatment, with multiple trials focusing on innovative therapies for reducing major adverse cardiovascular events.

• Atherosclerotic cardiovascular disease (ASCVD)
• Lipoprotein management
• Primary prevention strategies

Novel treatments including pelacarsen and inclisiran are being evaluated for their potential in cardiovascular risk reduction.

Comprehensive research into multiple sclerosis treatments, evaluating long-term safety and efficacy of innovative therapies for various forms of MS.

• Relapsing multiple sclerosis
• Migraine prevention
• Long-term treatment outcomes

Pioneering studies with medications like ocrelizumab and ofatumumab are advancing MS treatment options.

Groundbreaking research in gastrointestinal disorders, particularly focusing on Crohn's disease and ulcerative colitis treatments.

• Crohn's Disease management
• Ulcerative colitis therapy
• Novel oral treatments

Investigating new therapeutic approaches including TAK-279 and mirikizumab for moderate to severe disease states.

Innovative studies in rheumatoid arthritis treatment, exploring combination therapies for early-stage disease management.

• Early rheumatoid arthritis
• DMARD-naïve patients
• Combination therapy approaches

Evaluating the effectiveness of AP1189 in combination with traditional treatments for newly diagnosed patients.